top of page


All Posts


Clinical study start-up
Clinical study start-up begins long before the first patient is enrolled. A well-designed protocol is essential. Yet successful study execution also depends on realistic local feasibility, appropriate site and investigator selection, early regulatory and ethics planning, and operational readiness. At Prospective Research Services (PRS), we support international sponsors and CROs planning and conducting clinical research in Chile. By combining our local site and investigator d
50 minutes ago1 min read


Your Innovation, our Clinical Expertise
Your Innovation. Our Clinical Expertise. Behind every innovative medical device is a clinical development journey that requires the right expertise, local knowledge, and effective execution. At Prospective Research Services (PRS), we support international MedTech companies and CROs in navigating the clinical research landscape in Chile. From feasibility and site identification to regulatory and ethics submissions, study start-up, and clinical operations, we provide flexible,
1 hour ago1 min read


You Clinical operations partner in Chile
Clinical research is ultimately executed locally. Behind every study in Chile, there is a regulatory environment to understand, a network of sites and investigators to engage, and operational decisions that need to remain connected as the study progresses. Since 2014, Prospective Research Services (PRS) has worked alongside international sponsors and CROs, bringing local perspective to the execution of clinical research in Chile. In this brief presentation, we share how we ap
1 hour ago1 min read


Finding Your Ideal Latin America CRO Partnerships: Navigating Success in Clinical Research
In the intricate and ever-evolving landscape of clinical research, establishing a robust partnership with a Contract Research Organization (CRO) in Latin America is not merely advantageous but essential for achieving unparalleled success. The region's unique regulatory frameworks, diverse patient populations, and emerging markets demand a CRO partner who embodies expertise, reliability, and an intimate understanding of local nuances. As I delve into the critical factors that
Mar 235 min read


Nov 18, 20250 min read


What's New in Crohn's Disease Care? ACG Publishes Updated Guidelines
What’s New in Crohn’s Disease Care? ACG Publishes Updated Guidelines The American Journal of Gastroenterology (AJG) published in June 2025 the updated guideline on Crohn’s disease (CD), issued by the American College of Gastroenterology (ACG). This revision addresses the global increase in the incidence and prevalence of CD, along with the substantial growth in available therapeutic options since the previous guideline was released in 2018. The updated guideline aims to rev
Nov 18, 20251 min read


Scaling your Biotech Trials? LATAM Could Be the Advantage.
Expanding into LATAM? Here’s What You Should Know. At PRS, one of the most rewarding aspects of our work is seeing global clinical trials thrive in Latin America, driven by local teams, solid regulatory frameworks, and a deep commitment to patient-centered execution. These successes aren’t accidental — they’re the result of thoughtful planning, regulatory insight, and hands-on execution. If your company is planning to expand into LATAM, we’d be glad to share what we’ve lear
Nov 18, 20251 min read


Nov 18, 20250 min read


Nov 18, 20250 min read


Nov 17, 20250 min read


Nov 10, 20250 min read


Nov 10, 20250 min read


Nov 10, 20250 min read


What does success look like?
Redefining Success in Clinical Research—One Trial at a Time Success in clinical trials isn’t just about hitting milestones—it's about exceeding expectations while maintaining scientific and ethical integrity. Behind every successful clinical trial is a team that believes in precision, perseverance, and patient-centered progress.
Nov 4, 20251 min read


Nov 4, 20250 min read


Mid-Study Setbacks? It’s Not Too Late to Recover
Rescue. Realign. Relaunch. Supporting Your Trial When It Matters Most. Clinical trials often don’t proceed as planned. Delays, miscommunication, and local regulatory hurdles can slow down even the most promising studies, and timelines don’t wait. That’s where PRS comes in. We’re a Chile-based CRO with deep regional expertise and a hands-on, flexible approach. Our team is ready to step in when you need local support to keep things moving — or to get things back on track.
Nov 4, 20251 min read


From REMS to NAMs: Evolving FDA Revolutionary Regulatory Strategies in 2025
The Modernization Act 2.0 authorizes the use of certain alternatives to animal testing, including cell-based assays and computer models, to obtain an exemption from the Food and Drug Administration to investigate the safety and effectiveness of a drug. The bill also removes the requirement to use animal studies as part of the process to obtain a license for a biological product that is biosimilar or interchangeable with another biological product. These shifts open new doors
Oct 27, 20251 min read


Oct 25, 20250 min read


Oct 25, 20250 min read


Chile: The Strategic Choice for Global-Quality Clinical Execution
Why Chile Continues to Attract Global Sponsors Chile offers one of the most stable and efficient clinical research environments in LATAM — combining fast regulatory timelines, modern infrastructure, and motivated patient communities. At PRS, we work hand-in-hand with experienced Chilean investigators, top-performing sites, and accredited institutions. They are not only ICH/GCP-compliant and internationally trained but also fully aligned with evolving global standards and inno
Oct 25, 20251 min read

bottom of page
